NTRK1 and cancer: The blockage of NGF/Trk signaling with pan-Trk inhibitor PLX-7486 or the ablation of Tuft cells (a local source of ACh which stimulates cancer cells to produce NGF) within GC abrogates tumor development and decreases proliferation and tumorigenesis62.